MX9702531A - Compuesto nuevo. - Google Patents

Compuesto nuevo.

Info

Publication number
MX9702531A
MX9702531A MX9702531A MX9702531A MX9702531A MX 9702531 A MX9702531 A MX 9702531A MX 9702531 A MX9702531 A MX 9702531A MX 9702531 A MX9702531 A MX 9702531A MX 9702531 A MX9702531 A MX 9702531A
Authority
MX
Mexico
Prior art keywords
antibiotic activity
pneumocystis carinii
cyclic hexapeptides
activities
prophylactic
Prior art date
Application number
MX9702531A
Other languages
English (en)
Spanish (es)
Inventor
Hidenori Ohki
Masaki Tomishima
Akira Yamada
Hisashi Takasugi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26305774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9702531(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9420425A external-priority patent/GB9420425D0/en
Priority claimed from GBGB9508745.8A external-priority patent/GB9508745D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of MX9702531A publication Critical patent/MX9702531A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MX9702531A 1994-10-07 1995-09-29 Compuesto nuevo. MX9702531A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9420425A GB9420425D0 (en) 1994-10-07 1994-10-07 New compound
GBGB9508745.8A GB9508745D0 (en) 1995-04-28 1995-04-28 New compound
PCT/JP1995/001983 WO1996011210A1 (en) 1994-10-07 1995-09-29 Cyclic hexapeptides having antibiotic activity

Publications (1)

Publication Number Publication Date
MX9702531A true MX9702531A (es) 1997-06-28

Family

ID=26305774

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9702531A MX9702531A (es) 1994-10-07 1995-09-29 Compuesto nuevo.

Country Status (26)

Country Link
US (2) US6107458A (enExample)
EP (1) EP0788511B1 (enExample)
JP (2) JP2897427B2 (enExample)
KR (1) KR100353303B1 (enExample)
CN (1) CN1203089C (enExample)
AR (1) AR041770A1 (enExample)
AT (1) ATE229541T1 (enExample)
AU (1) AU696949B2 (enExample)
BR (2) BRPI9504791B8 (enExample)
CA (1) CA2202058C (enExample)
DE (2) DE122008000025I2 (enExample)
DK (1) DK0788511T3 (enExample)
ES (1) ES2187575T3 (enExample)
FI (1) FI119988B (enExample)
FR (1) FR08C0028I2 (enExample)
HU (1) HU228151B1 (enExample)
IL (1) IL115484A (enExample)
LU (1) LU91452I2 (enExample)
MX (1) MX9702531A (enExample)
NL (1) NL300352I2 (enExample)
NO (2) NO328483B1 (enExample)
OA (1) OA10475A (enExample)
PT (1) PT788511E (enExample)
RU (1) RU2165423C2 (enExample)
TR (1) TR199501229A2 (enExample)
WO (1) WO1996011210A1 (enExample)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
EP0994101A4 (en) * 1997-06-18 2002-05-02 Fujisawa Pharmaceutical Co NEW PREPARATION PROCESS
AU756792B2 (en) * 1998-02-09 2003-01-23 Fujisawa Pharmaceutical Co., Ltd. New compound
WO1999040108A1 (en) * 1998-02-09 1999-08-12 Fujisawa Pharmaceutical Co., Ltd. New compound
US7084279B1 (en) * 1999-02-11 2006-08-01 Emisphere Technologies Inc. Oxadiazole compounds and compositions for delivering active agents
EP1156787B1 (en) * 1999-02-11 2005-11-30 Emisphere Technologies, Inc. Oxadiazole compounds and compositions for delivering active agents
AUPP999799A0 (en) 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPQ066399A0 (en) * 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
JP2003505468A (ja) 1999-07-27 2003-02-12 アヴェンティス ファルマ ドイチェラント ゲーエムベーハー 新規なシクロヘキサペプチド化合物、それらの製造方法及びそれらの医薬品としての使用
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
TWI250992B (en) * 2000-02-21 2006-03-11 Astellas Pharma Inc Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms
ES2191516B1 (es) * 2000-07-28 2005-01-01 Consejo Superior De Investigaciones Cientificas Antibioticos antifungicos de naturaleza peptidica inhibidores de la germinacion y el crecimiento de hongos fitopatogenos.
AUPQ938700A0 (en) * 2000-08-14 2000-09-07 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
KR100777169B1 (ko) 2001-01-29 2007-11-16 시오노기세이야쿠가부시키가이샤 5-메틸-1-페닐-2-(1ｈ)-피리돈을 활성 성분으로서함유하는 의약 제제
JP2005053782A (ja) * 2001-08-31 2005-03-03 Fujisawa Pharmaceut Co Ltd 環状リポペプチド化合物の新規結晶
JP4784093B2 (ja) * 2002-08-08 2011-09-28 アステラス製薬株式会社 イソオキサゾリル安息香酸の製造法
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
DE602004010915T2 (de) * 2003-07-22 2008-12-11 Theravance, Inc., South San Francisco Verwendung eines antimykotischen echinocandin-mittels in kombination mit einem antibakteriellen glycopeptid-mittel
EP1663275A2 (en) * 2003-09-05 2006-06-07 Merck & Co., Inc. Stationary phases and a purification process using the stationary phases
JP4765627B2 (ja) * 2003-09-22 2011-09-07 Ｍｓｄ株式会社 新規ピペリジン誘導体
US7476673B2 (en) * 2003-12-30 2009-01-13 Allergan, Inc. Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
CA2566688A1 (en) * 2004-05-20 2005-12-01 The Scripps Research Institute Transthyretin stabilization
AR051202A1 (es) 2004-09-20 2006-12-27 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
WO2006034315A2 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
CA2580857A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CN101084212A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途
CA2580762A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
TW200626154A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
CN101083992A (zh) 2004-09-20 2007-12-05 泽农医药公司 抑制人硬脂酰CoA去饱和酶的哒嗪衍生物
CA2583976A1 (en) * 2004-10-13 2006-04-27 Ptc Therapeutics, Inc. Use of defined compounds for the manufacture of a medicament for preventing/treating diseases resulting from somatic mutations
EP2540296A1 (en) 2005-06-03 2013-01-02 Xenon Pharmaceuticals Inc. Arminothiazole derivatives as human stearoyl-coa desaturase inhibitors
WO2007043401A1 (ja) * 2005-10-07 2007-04-19 Kissei Pharmaceutical Co., Ltd. 含窒素複素環化合物およびそれを含有する医薬組成物
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
US8853392B2 (en) 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same
CA2699980C (en) 2007-08-13 2015-06-02 Divergence, Inc. Methods for the control of plant parasitic nematodes comprising application of oxadiazole compounds to plants, seeds or soil
BRPI0820409A2 (pt) * 2007-10-29 2015-05-19 Astellas Pharma Inc Composto de polipeptídeo
US8034806B2 (en) 2007-11-02 2011-10-11 Vanderbilt University Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
MX2010014569A (es) * 2008-06-24 2011-03-29 Irm Llc Compuestos y metodos para modular los receptores acoplados con proteina-g.
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
BR112013023531A2 (pt) 2011-04-04 2016-12-06 Xellia Pharmaceuticals Aps processo de um único vaso para a fabricação de micafungina ou de um sal desta
AU2012244435B2 (en) 2011-04-20 2017-06-15 Xellia Pharmaceuticals Aps Method for purification of Micafungin
CN102775476B (zh) 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
US9156830B2 (en) 2011-05-17 2015-10-13 Shionogi & Co., Ltd. Heterocyclic compounds
ES2586408T3 (es) 2011-09-09 2016-10-14 Sandoz Ag Preparación de intermedios de micafungina
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627688B (zh) 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
WO2015180682A1 (zh) * 2014-05-29 2015-12-03 上海天伟生物制药有限公司 一种环肽类化合物的溶剂合物及其制备方法和用途
CN104861043B (zh) * 2014-05-29 2019-03-01 上海天伟生物制药有限公司 一种环肽类化合物的组合物及其制备方法和用途
WO2016056023A2 (en) * 2014-10-07 2016-04-14 Alaparthi Lakshmi Prasad Intermediates and processes to prepare micafungin
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
PT3554474T (pt) 2016-12-16 2024-02-12 Baxter Healthcare Sa Composições de micafungina
EP3485873A1 (en) 2017-11-17 2019-05-22 Cadila Healthcare Limited Stable pharmaceutical injectable compositions of micafungin
CN108752430B (zh) * 2018-05-31 2022-02-18 杭州中美华东制药有限公司 米卡芬净钠新晶型及其制备方法
WO2020013116A1 (ja) * 2018-07-10 2020-01-16 京都薬品工業株式会社 Ｐｔｐ－１ｂ阻害剤およびその用途
CN110734408A (zh) * 2019-10-22 2020-01-31 重庆康乐制药有限公司 一种米卡芬净类衍生物侧链中间体的制备方法
CN115785226A (zh) * 2021-09-09 2023-03-14 上海天伟生物制药有限公司 一种棘白菌素药物杂质及其制备、纯化方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1574603A1 (ru) * 1988-08-11 1990-06-30 Ивановский Химико-Технологический Институт Способ получени мезо-тетраарилоктаметилпорфиринов
IE912046A1 (en) * 1990-06-18 1991-12-18 Fujisawa Pharmaceutical Co New polypeptide compound and a process for preparation¹thereof
CA2091663C (en) * 1992-03-19 2007-10-30 Frederick Joseph Burkhardt Cyclic peptide antifungal agents and process for preparation thereof

Also Published As

Publication number Publication date
LU91452I2 (fr) 2008-08-04
AU696949B2 (en) 1998-09-24
DE122008000025I1 (de) 2008-08-21
FR08C0028I1 (enExample) 2008-08-15
EP0788511A1 (en) 1997-08-13
FR08C0028I2 (enExample) 2009-11-20
DE122008000025I2 (de) 2011-02-17
RU2165423C2 (ru) 2001-04-20
HUT77736A (hu) 1998-07-28
IL115484A0 (en) 1996-01-19
NO971544L (no) 1997-06-04
CN1168675A (zh) 1997-12-24
WO1996011210A1 (en) 1996-04-18
JPH10324695A (ja) 1998-12-08
FI971397A0 (fi) 1997-04-04
CN1203089C (zh) 2005-05-25
JP3518665B2 (ja) 2004-04-12
TR199501229A2 (tr) 1996-07-21
US6107458A (en) 2000-08-22
PT788511E (pt) 2003-04-30
JP2897427B2 (ja) 1999-05-31
JPH10507174A (ja) 1998-07-14
HK1004136A1 (en) 1998-11-20
BR9504791B1 (pt) 2010-10-05
HU228151B1 (en) 2012-12-28
DE69529172D1 (de) 2003-01-23
NL300352I1 (nl) 2008-08-01
FI119988B (fi) 2009-05-29
BRPI9504791B8 (pt) 2019-12-31
IL115484A (en) 2000-07-16
KR970707150A (ko) 1997-12-01
US6265536B1 (en) 2001-07-24
AU3578095A (en) 1996-05-02
NO328483B1 (no) 2010-03-01
NO2010016I2 (no) 2011-10-17
KR100353303B1 (ko) 2003-01-15
FI971397L (fi) 1997-05-27
OA10475A (en) 2002-04-08
CA2202058A1 (en) 1996-04-18
DK0788511T3 (da) 2003-03-31
NL300352I2 (nl) 2008-11-03
CA2202058C (en) 2007-11-06
NO2010016I1 (no) 2010-08-16
NO971544D0 (no) 1997-04-04
ATE229541T1 (de) 2002-12-15
DE69529172T2 (de) 2003-04-17
AR041770A1 (es) 2005-06-01
ES2187575T3 (es) 2003-06-16
BR9504791A (pt) 1996-10-22
EP0788511B1 (en) 2002-12-11

Similar Documents

Publication Publication Date Title
MX9702531A (es) Compuesto nuevo.
CA2546625A1 (en) Glycopeptide antibiotic derivatives
BG94837A (bg) О-метилни производни на азитромицин а, метод за тяхното получаване и приложението им като фармацевтични препарати
AU3126097A (en) Collagen binding protein compositions and methods of use
DE69633613D1 (de) 2-Amino-2-(2-(4-octylphenyl)ethyl)propan-1,3-diol enthaltendes Arzneimittel zur topischen Anwendung zur Behandlung von Erkrankungen die durch eine Störung des Immunsystems hervorgerufen werden
TR200003064T2 (tr) Yeni bileşik
WO2002072621A3 (en) Cyclohexapeptide having antimicrobial activity
BRPI9708706C8 (pt) composição farmacêutica para administração intravenosa a um paciente
RU94008616A (ru) 2-тиозамещенные карбапенемы, промежуточные соединения для получения, способы получения, фармацевтическая композиция, способ лечения бактериальных инфекций
NO178343C (no) Fremgansmåte for fremstilling av terapeutisk aktiv 1-[4,5-dihydroksy-N2-(10,12-dimethyl-1-oxotetradecyl)-ornithinÅ-5-(3-hydroxyglutamin)-6-[3-hydroxyprolinÅechinocandin B
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
BG101570A (bg) Производни на еритромицин а 9-0-оксим, притежаващи антибиотична активност
DE69419782D1 (de) Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung
EP0149254A2 (en) Fungicidal polypeptide compositions containing L-histidine
EP0287110A3 (en) Glycopeptide antibiotics pa-45052
CA2428662A1 (en) Small acid-soluble spore protein and uses thereof
CA2221793A1 (en) Novel antibacterial protein
WO2003068807A3 (en) Echinocandin cyclic peptide derivatives
DK0675900T3 (da) Antibiotika GE 37468 A, B og C
RU95105249A (ru) Гидрохлорид ng монометил-l-аргинина, способы его получения, способ получения фармацевтического препарата и способ лечения
YU169090A (sh) Tetra hidroimidazo (1,4) benzodiazepini
RU94004998A (ru) Хризоспермины, способ их получения, лекарственное средство на их основе и штамм apiocrea chrysosperma
HU9300553D0 (en) Complex antibiotic ge1655 its a, d and c factors, method for producing them, agricultural and pharmaceutical preparatives containing them as well as method for preparing said preparatives